Unit Head

Honorary Professor Rod Dawson

MBChB (Stell), FCP (SA), Cert. Pulm (SA)

Honorary Professor Rod Dawson established the Centre for Tuberculosis Research Innovation at the University of Cape Town Lung Institute in 2007. He is a qualified Consultant Pulmonologist and has a special interest in chest radiology, tuberculosis and HIV infection. Honorary Professor Rod Dawson was appointed Director of the University of Cape Town Lung Institute in 2016.


Centre for TB Research Innovation (CTBRI)

The mandate of the UCT Lung Institute is to address priority health issues through, education, research and service. Since 2008 CTBRI has conducted research into tuberculosis with focus areas of TB drug development, HIV/TB interaction, effects of smoking in TB and HIV and understanding adherence to medication in drug-resistant TB.

“Worldwide incidence of tuberculosis in 2019: 10 million cases”
“Worldwide 1,2 million deaths from tuberculosis”
“60% of deaths occur in only 6 countries: Malaysia, India, China, Nigeria, Pakistan and South Africa”

RELEVANCE

Advancing new treatment solutions for tuberculosis and HIV

EXCELLENCE

Setting the standard for clinical trials

RESPECT

Transforming life for our patients
The 2020 WHO Global Tuberculosis Report estimates that in 2019 there were 10 million cases of tuberculosis worldwide. Tuberculosis remains a top 10 cause of death with more than 1.2 milliion people dying annually. 60% of these deaths occur in only 6 countries: Malaysia, India, China, Nigeria, Pakistan and South Africa. TB is the principal cause of death in South Africa.

CTBRI news

27th January 2023

As with Covid-19, the effects of TB can linger after it is cured.

According to the World Health Organization, of the roughly 10 million people who fall ill with TB annually, over 80% survive. Unfortunately, as with long Covid, being cured of TB is not always the last hurdle and many people go on to struggle with post-TB lung disease. Tiyese Jeranji asked local experts about this sometimes-neglected area of TB care.